FDA greenlights new gout drug

New drug may bring relief to patients

The FDA is giving the green light to a new drug to aid patients with gout. Gout is a buildup of uric acid in the joints and which in some patients may feel like a “heart-attack” of the foot. The ADC rheumatology physician group participated in clinical studies for this new medication which is expected to be available for doctors to prescribe over the next 4 to 8 weeks.

It is currently not covered by insurance, but ADC rheumatologist Dr. Chris Parker says eventually the insurance companies will cover its use. The new drug Zurampic is used as an adjunct to medications a patient may already being using. Dr. Parker says it will be used in those patients who have the most painful flare ups. In the interview above, he discusses gout and the new medication with KXAN’s Erin Cargile.

Patients affected by gout also have a new support and education group available to them. As Dr. Parker notes, because of the painful nature of gout, many individuals feel isolated with this disease. He says the group is one way to get patients sharing information and supporting each other.   The next meeting is April 30 in the ADC Rheumatology north office at 12221 MoPac Expressway North, 3rd floor, south entrance, 78758. The Austin Gout Education and Support group is free and open to the public. For more information visit the ADC event calendar.